array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(682)
}
["articles"]=>
array(5) {
[0]=>
array(7) {
["title_en"]=>
string(7) "Bio-Rad"
["snippet_en"]=>
string(89) "Design, development & contract manufacturing news coverage of medical devices & equipment"
["url"]=>
string(96) "https://www.medicaldesignandoutsourcing.com/2023-Medical-Design-and-Outsourcing-BIG-100/bio-rad/"
["image_url"]=>
NULL
["source"]=>
string(31) "medicaldesignandoutsourcing.com"
["publication_date"]=>
string(10) "2023-08-10"
["categories"]=>
array(1) {
[0]=>
string(15) "Deals & Tenders"
}
}
[1]=>
array(7) {
["title_en"]=>
string(52) "Bio-Rad Laboratories in Talks to Combine With Qiagen"
["snippet_en"]=>
string(73) "Deal between life-sciences companies would be worth more than $10 billion"
["url"]=>
string(93) "https://www.wsj.com/articles/bio-rad-laboratories-in-talks-to-combine-with-qiagen-11665424987"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/ba7eb2fd-bd2f-4330-9f76-686f37754015"
["source"]=>
string(7) "wsj.com"
["publication_date"]=>
string(10) "2022-10-10"
["categories"]=>
array(1) {
[0]=>
string(15) "Deals & Tenders"
}
}
[2]=>
array(7) {
["title_en"]=>
string(80) "Luminex and Bio-Rad Extend Their Global Sales and Distribution Agreement to 2023"
["snippet_en"]=>
string(161) "/PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has extended its global sales and distribution agreement with Bio-Rad Laboratories,..."
["url"]=>
string(136) "https://www.prnewswire.com/news-releases/luminex-and-bio-rad-extend-their-global-sales-and-distribution-agreement-to-2023-145890205.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/cce0ca2f-9ce4-4a9d-960c-169948cf7987"
["source"]=>
string(14) "prnewswire.com"
["publication_date"]=>
string(10) "2012-04-03"
["categories"]=>
array(3) {
[0]=>
string(13) "Collaboration"
[1]=>
string(15) "Deals & Tenders"
[2]=>
string(21) "Financial Performance"
}
}
[3]=>
array(7) {
["title_en"]=>
string(75) "Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement"
["snippet_en"]=>
string(292) "Bio-Rad Laboratories, Inc.( NYSE: BIO and BIOb) and QIAGEN N.V.( NYSE: QGEN; Frankfurt Prime Standard: QIA), today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing"
["url"]=>
string(137) "https://www.morningstar.com/news/business-wire/20230726552882/bio-rad-and-qiagen-announce-patent-settlement-and-cross-licensing-agreement"
["image_url"]=>
NULL
["source"]=>
string(15) "morningstar.com"
["publication_date"]=>
NULL
["categories"]=>
array(5) {
[0]=>
string(13) "Collaboration"
[1]=>
string(27) "Business Model & Innovation"
[2]=>
string(15) "Deals & Tenders"
[3]=>
string(16) "Case Settlements"
[4]=>
string(5) "Legal"
}
}
[4]=>
array(7) {
["title_en"]=>
string(52) "Bio-Rad strikes $170M deal for Curiosity Diagnostics"
["snippet_en"]=>
string(286) "Bio-Rad Laboratories Inc. signed a $170 million deal to acquire all the outstanding shares of molecular diagnostics subsidiary Curiosity Diagnostics SpZoo from Scope Fluidics SA. The deal consists of approximately $100 million in cash and up to $70 million in future milestone payments."
["url"]=>
string(92) "https://www.bioworld.com/articles/521301-bio-rad-strikes-170m-deal-for-curiosity-diagnostics"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/984f2b66-94ae-4d29-96ea-ac3713e4bf57"
["source"]=>
string(12) "bioworld.com"
["publication_date"]=>
NULL
["categories"]=>
array(3) {
[0]=>
string(11) "Acquisition"
[1]=>
string(14) "Issuing Shares"
[2]=>
string(15) "Deals & Tenders"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(32)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(30)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(15)
}
[13]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(10)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(10)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
682 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
/PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has extended its global sales and distribution agreement with Bio-Rad Laboratories,...
Bio-Rad Laboratories, Inc.( NYSE: BIO and BIOb) and QIAGEN N.V.( NYSE: QGEN; Frankfurt Prime Standard: QIA), today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing
Bio-Rad Laboratories Inc. signed a $170 million deal to acquire all the outstanding shares of molecular diagnostics subsidiary Curiosity Diagnostics SpZoo from Scope Fluidics SA. The deal consists of approximately $100 million in cash and up to $70 million in future milestone payments.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
